NUCKS Is a Positive Transcriptional Regulator of Insulin Signaling

Cell Reports

Volumn 7, Issue 6, 2014, Pages 1876-1886

  Qiu, Beiying ^a   Shi, Xiaohe ^b   Wong, EeTsin ^a   Lim, Joy ^b   Bezzi, Marco ^a   Low, Diana ^a   Zhou, Qiling ^a   Akincilar, SemihCan ^a   Lakshmanan, Manikandan ^a   Swa, Hannah L F ^a   Tham, JillMaeLan ^a   Gunaratne, Jayantha ^a   Cheng, Kenneth K Y ^c   Hong, Wanjin ^a   Lam, Karen S L ^c   Ikawa, Masahito ^d   Guccione, Ernesto ^a   Xu, Aimin ^c,e   Han, Weiping ^b,f   Tergaonkar, Vinay ^a,f  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; NUCKS PROTEIN; PROTEIN KINASE B; REGULATOR PROTEIN; RNA POLYMERASE II; UNCLASSIFIED DRUG; NUCKS PROTEIN, HUMAN; NUCKS PROTEIN, MOUSE; NUCLEAR PROTEIN; PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENDOCRINE CELL; ENZYME ACTIVATION; FAT MASS; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WEIGHT GAIN; ANIMAL; BODY WEIGHT; GENETICS; GLUCOSE INTOLERANCE; KNOCKOUT MOUSE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; TRANSCRIPTION INITIATION;

MUS;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84903481858     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.030     Document Type: Article

References (34)

1. Ang H.L., Tergaonkar V. Notch and NFkappaB signaling pathways: do they collaborate in normal vertebrate brain development and function?. BioEssays 2007, 29:1039-1047.
2. Bozulic L., Hemmings B.A. PIKKing on PKB: regulation of PKB activity by phosphorylation. Curr. Opin. Cell Biol. 2009, 21:256-261.
3. Brunetti A., Manfioletti G., Chiefari E., Goldfine I.D., Foti D. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J. 2001, 15:492-500.
4. Cildir G., Akincilar S.C., Tergaonkar V. Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol. Med. 2013, 19:487-500.
5. Dang C.V. MYC on the path to cancer. Cell 2012, 149:22-35.
6. Drosos Y., Kouloukoussa M., Østvold A.C., Grundt K., Goutas N., Vlachodimitropoulos D., Havaki S., Kollia P., Kittas C., Marinos E., Aleporou-Marinou V. NUCKS overexpression in breast cancer. Cancer Cell Int. 2009, 9:19.
7. Emanuelli B., Peraldi P., Filloux C., Sawka-Verhelle D., Hilton D., Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J.Biol. Chem. 2000, 275:15985-15991.
8. Foti D., Iuliano R., Chiefari E., Brunetti A. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol. Cell. Biol. 2003, 23:2720-2732.
9. Foti D., Chiefari E., Fedele M., Iuliano R., Brunetti L., Paonessa F., Manfioletti G., Barbetti F., Brunetti A., Croce C.M., et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat. Med. 2005, 11:765-773.
10. Friedman J.M. Obesity: Causes and control of excess body fat. Nature 2009, 459:340-342.
11. González-Rodríguez A., Mas Gutierrez J.A., Sanz-González S., Ros M., Burks D.J., Valverde A.M. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes 2010, 59:588-599.
12. Grundt K., Skjeldal L., Anthonsen H.W., Skauge T., Huitfeldt H.S., Østvold A.C. A putative DNA-binding domain in the NUCKS protein. Arch. Biochem. Biophys. 2002, 407:168-175.
13. Grundt K., Haga I.V., Huitfeldt H.S., Ostvold A.C. Identification and characterization of two putative nuclear localization signals (NLS) in the DNA-binding protein NUCKS. Biochim. Biophys. Acta 2007, 1773:1398-1406.
14. Gustavsson N., Lao Y., Maximov A., Chuang J.C., Kostromina E., Repa J.J., Li C., Radda G.K., Südhof T.C., Han W. Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice. Proc. Natl. Acad. Sci. USA 2008, 105:3992-3997.
15. Hatada E.N., McClain D.A., Potter E., Ullrich A., Olefsky J.M. Effects of growth and insulin treatment on the levels of insulin receptors and their mRNA in Hep G2 cells. J.Biol. Chem. 1989, 264:6741-6747.
16. Inoue G., Cheatham B., Emkey R., Kahn C.R. Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J.Biol. Chem. 1998, 273:11548-11555.
17. Kitamura T., Kahn C.R., Accili D. Insulin receptor knockout mice. Annu. Rev. Physiol. 2003, 65:313-332.
18. Leavens K.F., Birnbaum M.J. Insulin signaling to hepatic lipid metabolism in health and disease. Crit. Rev. Biochem. Mol. Biol. 2011, 46:200-215.
19. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
20. Meijer L., Ostvold A.C., Walass S.I., Lund T., Laland S.G. High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase. Eur. J. Biochem. 1991, 196:557-567.
21. Migliori V., Müller J., Phalke S., Low D., Bezzi M., Mok W.C., Sahu S.K., Gunaratne J., Capasso P., Bassi C., et al. Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance. Nat. Struct. Mol. Biol. 2012, 19:136-144.
22. Ostvold A.C., Haddeland U., Laland S.G. The ubiquity of the highly phosphorylated nuclear protein P1. Biochem. Int. 1990, 20:991-1000.
23. Puig O., Tjian R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 2005, 19:2435-2446.
24. Ramachandrappa S., Farooqi I.S. Genetic approaches to understanding human obesity. J.Clin. Invest. 2011, 121:2080-2086.
25. Rui L., Yuan M., Frantz D., Shoelson S., White M.F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J.Biol. Chem. 2002, 277:42394-42398.
26. Simon J.M., Giresi P.G., Davis I.J., Lieb J.D. Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA. Nat. Protoc. 2012, 7:256-267.
27. Sleeman M.W., Wortley K.E., Lai K.M., Gowen L.C., Kintner J., Kline W.O., Garcia K., Stitt T.N., Yancopoulos G.D., Wiegand S.J., Glass D.J. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 2005, 11:199-205.
28. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7:85-96.
29. Tergaonkar V. NFkappaB pathway: a good signaling paradigm and therapeutic target. Int. J. Biochem. Cell Biol. 2006, 38:1647-1653.
30. Trajkovski M., Hausser J., Soutschek J., Bhat B., Akin A., Zavolan M., Heim M.H., Stoffel M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011, 474:649-653.
31. Vollenweider P., Ménard B., Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3' kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 2002, 51:1052-1059.
32. Wiśniewski J.R., Zougman A., Krüger S., Ziółkowski P., Pudełko M., Bebenek M., Mann M. Constitutive and dynamic phosphorylation and acetylation sites on NUCKS, a hypermodified nuclear protein, studied by quantitative proteomics. Proteins 2008, 73:710-718.
33. Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE 2005, 2005:pe4.
34. Ziółkowski P., Gamian E., Osiecka B., Zougman A., Wiśniewski J.R. Immunohistochemical and proteomic evaluation of nuclear ubiquitous casein and cyclin-dependent kinases substrate in invasive ductal carcinoma of the breast. J.Biomed. Biotechnol. 2009, 2009:919645.